Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Asia | 154.7 | 187.2 | | 256.2 | 295.8 | 281.6 | 225.2 | 167.8 |
| Other | 337.7 | 361.0 | | 244.0 | 271.3 | 205.4 | 124.0 | 118.8 |
| Total revenues [+] | 492.4 | 548.2 | 491.6 | 500.2 | 567.1 | 487.1 | 349.2 | 286.6 |
| Products | | | | | | | 349.2 | 286.6 |
| Revenue growth [+] | -10.2% | 11.5% | -1.7% | -11.8% | 16.4% | 39.5% | 21.8% | -2.9% |
| Asia | -17.3% | | | -13.4% | 5.0% | 25.1% | 34.2% | 32.2% |
| Europe | | | | -41.7% | 5.2% | 247.2% | 22.2% | -0.1% |
| Cost of goods sold | 381.7 | 408.9 | 389.3 | 400.2 | 458.3 | 399.7 | 287.0 | 240.1 |
| Gross profit | 110.7 | 139.3 | 102.3 | 99.9 | 108.8 | 87.4 | 62.2 | 46.5 |
| Gross margin | 22.5% | 25.4% | 20.8% | 20.0% | 19.2% | 17.9% | 17.8% | 16.2% |
| Selling, general and administrative | 76.1 | 82.6 | 84.7 | 71.0 | 78.0 | 72.1 | 45.8 | 39.6 |
| Research and development | 26.9 | 29.5 | | | | | | |
| Other operating expenses | -1.7 | 0.2 | 0.3 | 2.1 | 2.1 | 1.8 | 1.4 | |
| EBITDA [+] | 25.8 | 45.2 | 38.1 | 48.6 | 51.8 | 33.8 | 27.4 | 16.0 |
| EBITDA growth | -42.8% | 18.5% | -21.6% | -6.1% | 53.0% | 23.4% | 71.2% | -18.9% |
| EBITDA margin | 5.2% | 8.2% | 7.8% | 9.7% | 9.1% | 6.9% | 7.9% | 5.6% |
| Depreciation | 10.1 | 11.8 | 14.0 | 14.8 | 16.0 | 15.0 | 10.5 | 8.3 |
| EBITA | 15.8 | 33.3 | 24.1 | 33.8 | 35.8 | 18.9 | 16.9 | 7.7 |
| EBITA margin | 3.2% | 6.1% | 4.9% | 6.8% | 6.3% | 3.9% | 4.9% | 2.7% |
| Amortization of intangibles | 6.4 | 6.4 | 6.7 | 7.0 | 7.0 | 5.4 | 1.9 | 0.8 |
| EBIT [+] | 9.4 | 26.9 | 17.4 | 26.8 | 28.8 | 13.5 | 15.0 | 6.9 |
| EBIT growth | -65.2% | 55.0% | -35.2% | -6.8% | 113.5% | -10.5% | 117.8% | -37.7% |
| EBIT margin | 1.9% | 4.9% | 3.5% | 5.4% | 5.1% | 2.8% | 4.3% | 2.4% |
| Non-recurring items [+] | 8.9 | | | 103.3 | 0.2 | | | 5.2 |
| Asset impairment | 8.9 | | | 106.0 | | | | |
| Loss (gain) on disposal of assets | | | | -2.6 | 0.2 | | | |
| Interest expense, net [+] | 5.4 | 5.3 | 6.8 | 6.0 | 2.9 | 3.7 | 0.2 | 0.0 |
| Interest expense | 5.4 | 5.3 | 6.8 | 6.7 | 7.6 | 4.0 | 0.2 | 0.0 |
| Interest income | | | | 0.6 | 4.7 | 0.3 | | |
| Other income (expense), net [+] | -2.3 | 2.0 | -0.9 | | | | 0.3 | -0.7 |
| Asset impairment charges | | | | | | | | -0.8 |
| Gain (loss) on sale of assets | -4.3 | | | | | | | |
| Gain (loss) on investments | | | | | | | | -0.8 |
| Other | | | | | | | 0.3 | 0.1 |
| Pre-tax income | -7.3 | 23.6 | 9.6 | -82.6 | 25.7 | 9.8 | 15.2 | 1.0 |
| Income taxes | 1.4 | 2.9 | 21.5 | -17.7 | 6.5 | 1.2 | -0.7 | -1.4 |
| Tax rate | | 12.3% | 223.4% | 21.5% | 25.4% | 11.9% | | |
| Net income | -8.7 | 20.7 | -11.9 | -64.8 | 19.2 | 8.6 | 15.9 | 2.4 |
| Net margin | -1.8% | 3.8% | -2.4% | -13.0% | 3.4% | 1.8% | 4.6% | 0.8% |
| |
| Basic EPS [+] | ($0.71) | $1.71 | ($0.99) | ($5.44) | $1.62 | $0.74 | $7,314.02 | $1,091.03 |
| Growth | -141.6% | -272.9% | -81.8% | -436.3% | 119.3% | -100.0% | 570.4% | -37.0% |
| Diluted EPS [+] | ($0.71) | $1.71 | ($0.99) | ($5.44) | $1.62 | $0.74 | $7,314.02 | $1,091.03 |
| Growth | -141.6% | -272.9% | -81.8% | -436.3% | 119.3% | -100.0% | 570.4% | -37.0% |
| |
| Dividends per share [+] | $0.27 | $0.27 | $0.27 | $0.27 | $0.27 | $0.27 | $1,430.34 | $1,482.76 |
| Growth | 0.3% | -0.3% | 0.2% | -0.2% | 0.7% | -100.0% | -3.5% | 0.6% |
| |
| Shares outstanding (basic) [+] | 12.3 | 12.1 | 12.0 | 11.9 | 11.9 | 11.7 | 0.0 | 0.0 |
| Growth | 1.4% | 0.7% | 0.9% | 0.4% | 1.8% | 536267.8% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 12.3 | 12.1 | 12.0 | 11.9 | 11.9 | 11.7 | 0.0 | 0.0 |
| Growth | 1.4% | 0.7% | 0.9% | 0.4% | 1.8% | 536267.8% | 0.0% | 0.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|